Today, $AMGN (+0,79%) reached my predefined take-profit target, automatically closing the position.
Following the principles of my Blue Chip Fibonacci Portfolio, I realized the gains and then reassessed the company.
My conclusion? Still a Blue Chip stock.
Amgen remains one of the leading biotechnology stocks, with a strong product portfolio, solid profitability, and continued investment in future growth areas. That's why I opened a new position immediately after closing the previous one.
Some investors hold indefinitely. Others sell and move on.
I prefer to:
✅ Realize gains systematically
✅ Reset the cycle
✅ Re-enter when the thesis remains valid
Now let's see how the next chapter unfolds.
#trading
#profit
#gains
#long
#tradingstrategy
#amgn
#amgen
#stocks
#usa
#biotech
#healthcare
#bluechipfibonacci
#mikeupegui
